title: Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
authors.affiliation: Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: amartya.kundu@umassmemorial.org.
authors.forename: Amartya
authors.initials: A
authors.lastname: Kundu
authors.affiliation: Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, USA.
authors.forename: Partha
authors.initials: P
authors.lastname: Sardar
authors.affiliation: Department of Medicine, Interfaith Medical Center, Brooklyn, NY, USA.
authors.forename: Sreeparna
authors.initials: S
authors.lastname: Ghosh
authors.affiliation: Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
authors.forename: Parth
authors.initials: P
authors.lastname: Patel
authors.affiliation: Division of Cardiology, St Luke's-Roosevelt Hospital of the Mount Sinai Health System, New York, NY, USA.
authors.forename: Saurav
authors.initials: S
authors.lastname: Chatterjee
authors.affiliation: Department of Medicine, Division of Cardiology, University of Massachusetts Medical School, Worcester, MA, USA.
authors.forename: Theo E
authors.initials: TE
authors.lastname: Meyer
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006333:Heart Failure / Q000139:chemically induced / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors
keywords: Alogliptin; Diabetes mellitus; Dipeptidyl peptidase-4 inhibitors; Heart failure; Saxagliptin; Sitagliptin